Recent Industry Personnel Changes
Monday, March 26, 2007
- Premier Research Group, a Philadelphia-based contract research organization (CRO), appointed Troy McCall, Ph.D., as the company’s new chief operating officer. He will be responsible for Premier’s global clinical trial operations. McCall is returning to the company after leaving Premier as vice president of business development to become president and chief executive officer of eClinical firm, Advanced Clinical Research Services (ACRS).
- Waltham, Mass.-based CRO Parexel named Matthias Grossmann, M.D. and James Wong, Ph.D., to the company’s clinical pharmacology network. Grossmann and Wong have been appointed to vice president of the clinical pharmacology services. Prior to Parexel, Grossman was head of medical affairs at a pharmacology research group in Mannheim, Germany. Before joining Parexel, Wong was the director of clinical pharmacology at The Medicines Company and has held senior positions at AstraZeneca and Schering AG. Grossman will be based in its pharmacology facility in Berlin, while Wong will work out of the company’s Baltimore unit.
- Cincinnati-based CRO Kendle has appointed Thomas Smith, M.D., to the position of global medical director. He will be responsible for providing medical expertise to the company’s clinical development programs and provide insights for new client proposals. He will have a particular role in CNS related projects. Prior to joining Smith was a senior director of clinical research and development at Akros Pharma. He has also held various positions at Genzyme and Abbott Laboratories.